Home/Filings/4/0001181431-09-011158
4//SEC Filing

Moreadith Randall W 4

Accession 0001181431-09-011158

CIK 0000906709other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 12:15 PM ET

Size

5.9 KB

Accession

0001181431-09-011158

Insider Transaction Report

Form 4
Period: 2009-02-23
Moreadith Randall W
SVP Drug Development
Transactions
  • Award

    Employee Stock Option

    2009-02-23$4.65/sh+85,000$395,25085,000 total
    Exercise: $4.65Exp: 2017-02-23Common Stock (85,000 underlying)
Footnotes (2)
  • [F1]Annual equity grant.
  • [F2]The shares subject to the employee stock option vest on a monthly pro-rata basis over four years with all of such shares vesting on February 23, 2013.

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1
  • filerCIK 0001442100

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 12:15 PM ET
Size
5.9 KB